Europe - Frankfurt Stock Exchange - FRA:ELAA - US5184391044 - Common Stock
The current stock price of ELAA.DE is 76.8 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LOR.DE | L'OREAL | 28.65 | 195.01B | ||
| OR.PA | L'OREAL | 28.8 | 195.99B | ||
| BEI.DE | BEIERSDORF AG | 23.33 | 22.35B | ||
| ITP.PA | INTERPARFUMS SA | 13.66 | 2.00B | ||
| ICOS.MI | INTERCOS SPA | 23.84 | 1.13B | ||
| ONTEX.BR | ONTEX GROUP NV | N/A | 520.45M | ||
| PHN.MI | PHARMANUTRA SPA | 22.53 | 534.34M | ||
| JBOG.PA | JACQUES BOGART | N/A | 70.29M | ||
| ENV.MI | ENERVIT | 14.96 | 66.57M |
The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. The company is headquartered in New York City, New York and currently employs 62,000 full-time employees. Its product categories include skin care, makeup, fragrance, hair care and other. The firm's products are sold in approximately 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD. The company is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, acne and oil correctors, facial masks, and sun care products. Its makeup products include lipsticks, lip glosses, mascaras, foundations and others.
ESTEE LAUDER COMPANIES-CL A
767 5th Ave
New York City NEW YORK US
Employees: 62000
Phone: 12125724200
The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. The company is headquartered in New York City, New York and currently employs 62,000 full-time employees. Its product categories include skin care, makeup, fragrance, hair care and other. The firm's products are sold in approximately 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD. The company is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, acne and oil correctors, facial masks, and sun care products. Its makeup products include lipsticks, lip glosses, mascaras, foundations and others.
The current stock price of ELAA.DE is 76.8 EUR. The price increased by 0.79% in the last trading session.
ESTEE LAUDER COMPANIES-CL A (ELAA.DE) has a dividend yield of 2.38%. The yearly dividend amount is currently 2.59.
ELAA.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
36 analysts have analysed ELAA.DE and the average price target is 144.28 EUR. This implies a price increase of 87.86% is expected in the next year compared to the current price of 76.8.
The Revenue of ESTEE LAUDER COMPANIES-CL A (ELAA.DE) is expected to decline by -1.34% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ESTEE LAUDER COMPANIES-CL A (ELAA.DE) has a market capitalization of 27.54B EUR. This makes ELAA.DE a Large Cap stock.
ChartMill assigns a technical rating of 2 / 10 to ELAA.DE.
ChartMill assigns a fundamental rating of 4 / 10 to ELAA.DE. ELAA.DE has only an average score on both its financial health and profitability.
Over the last trailing twelve months ELAA.DE reported a non-GAAP Earnings per Share(EPS) of 1.76. The EPS decreased by -46.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.17% | ||
| ROA | 2.82% | ||
| ROE | 11.16% | ||
| Debt/Equity | 1.26 |
36 analysts have analysed ELAA.DE and the average price target is 144.28 EUR. This implies a price increase of 87.86% is expected in the next year compared to the current price of 76.8.
For the next year, analysts expect an EPS growth of -33.25% and a revenue growth -1.34% for ELAA.DE